A meta-analysis from 2001, spanning 12 studies with normotensive individuals with type 1 diabetes and moderate albuminuria, landed at an odds ratio of 3.07 for regression to normal AER in the ACE-inihibtor arm vs. placebo/nonintervention group (67). The gene discussed is ACE; the disease is type 1 diabetes mellitus.